Somatuline Autogel: an extended release lanreotide formulation

被引：22

作者：

Lightman, S ^{[1
]}

机构：

[1] Univ Bristol, Bristol Royal Infirm, Bristol BS2 8HW, Avon, England

来源：

HOSPITAL MEDICINE | 2002年 / 63卷 / 03期

关键词：

D O I：

10.12968/hosp.2002.63.3.2062

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Somatuline Autogel provides effective control of growth hormone levels and is at least as effective as intramuscular Somatuline LA. Somatuline Autogel has a first order kinetic profile providing at least 28 days' efficacy with reduced burst release and a more consistent drug release over the dose period. The product is presented in a pre-filled syringe and is given deep subcutaneously.

引用

收藏

页码：162 / 165

页数：4

相关论文

共 16 条

[1] EPIDEMIOLOGY OF ACROMEGALY IN THE NEWCASTLE REGION [J].

ALEXANDER, L ;

APPLETON, D ;

HALL, R ;

ROSS, WM ;

WILKINSON, R .

CLINICAL ENDOCRINOLOGY, 1980, 12 (01) :71-79

[2] The effect of a new slow-release, long-acting somatostatin analogue, lanreotide, in acromegaly [J].

AlMaskari, M ;

Gebbie, J ;

KendallTaylor, P .

CLINICAL ENDOCRINOLOGY, 1996, 45 (04) :415-421

[3]

BATES AS, 1993, Q J MED, V86, P296

[4] Three year follow-up of acromegalic patients treated with intramuscular slow-release lanreotide [J].

Caron, P ;

MorangeRamos, I ;

Cogne, M ;

Jaquet, P .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (01) :18-22

[5] Efficacy of the new long-acting formulation of lanreotide (lanreotide Autogel) in the management of acromegaly [J].

Caron, P ;

Beckers, A ;

Cullen, DR ;

Goth, MI ;

Gutt, B ;

Laurberg, P ;

Pico, AM ;

Valimaki, M ;

Zgliczynski, W .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (01) :99-104

[6]

CHANSON P, 1995, 13 FRENCH C END NANC

[7] Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly: Six-month report on an Italian multicenter study [J].

Giusti, M ;

Gussoni, G ;

Cuttica, CM ;

Giordano, G ;

Camanni, F ;

Ciccarelli, E ;

Dallabonzana, D ;

Strada, S ;

Delitala, G ;

Porcu, L ;

Faglia, G ;

Arosio, M ;

Liuzzi, A ;

Ghiggi, MR .

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) :2089-2097

[8] The pharmacological aspects of the treatment of acromegaly [J].

Giustina, A ;

Zaltieri, G ;

Negrini, F ;

Wehrenberg, WB .

PHARMACOLOGICAL RESEARCH, 1996, 34 (5-6) :247-268

[9] MEDICAL PROGRESS - ACROMEGALY [J].

MELMED, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (14) :966-977

[10]

O'Toole D, 2000, CANCER, V88, P770, DOI 10.1002/(SICI)1097-0142(20000215)88:4<770::AID-CNCR6>3.0.CO